Rapid cognitive screening of patients with substance use disorders.
Rapid cognitive screening of patients with substance use disorders.
复制标题
DOI：
10.1037/a0017260
复制
发表时间：
2009-10
影响因子：
2.3
通讯作者：
Weiss, Roger D.
中科院分区：
文献类型：
--
作者：
Copersino, Marc L.;Fals-Stewart, William;Fitzmaurice, Garrett;Schretlen, David J.;Sokoloff, Jody;Weiss, Roger D.
关键词：
到目前为止，还没有一个时间效率和资源意识的方法来识别物质使用障碍（SUD）患者的认知障碍。本研究评估的有效性，准确性和临床效用的一个简短的（10分钟）筛选工具，蒙特利尔认知评估（莫卡），在识别认知功能障碍的SUD患者。神经心理学评估组合筛选模块（NAB-SM）是一种45分钟的组合，对SUD患者中观察到的轻度至中度缺陷具有已知的敏感性，被用作确定莫卡的一致性、正确和不正确决策分类率以及标准相关有效性的参考标准。基于受试者操作特征（ROC）分析，莫卡的分类准确性很高，ROC曲线下面积= 0.86 [95%CI：0.75-0.97]。莫卡在识别认知功能障碍方面的敏感性（83.3%）和特异性（72.9%）也可接受。使用莫卡的临界值25，总体一致性为75.0%;机会校正一致性（kappa）为41.9%。这些研究结果表明，莫卡提供了一种时间效率和资源意识的方式来识别SUD患者的神经心理障碍，从而解决了成瘾治疗研究界的关键需求。
To date, there has not been a time-efficient and resource-conscious way to identify cognitive impairment in patients with substance use disorders (SUD). The present study assesses the validity, accuracy, and clinical utility of a brief (10 min) screening instrument, the Montreal Cognitive Assessment (MoCA), in identifying cognitive impairment among SUD patients. The Neuropsychological Assessment Battery-Screening Module (NAB-SM), a 45-minute battery with known sensitivity to the mild-to-moderate deficits observed in SUD patients, was used as the reference criterion for determining agreement, rates of correct and incorrect decision classifications, and criterion-related validity for the MoCA. Classification accuracy of the MoCA, based on receiver-operating characteristic (ROC) analysis, was strong, with an area under the ROC curve = 0.86 [95% CI: 0.75-0.97]. The MoCA also showed acceptable sensitivity (83.3%) and specificity (72.9%) for the identification of cognitive impairment. Using a cut-off of 25 on the MoCA, the overall agreement was 75.0%; chance-corrected agreement (kappa) was 41.9%. These findings indicate that the MoCA provides a time-efficient and resource-conscious way to identify SUD patients with neuropsychological impairment, thus addressing a critical need in the addiction treatment research community.
登录
查看更多内容
影响因子：
4.2
作者：
Aharonovich, E;Hasin, DS;Nunes, EV
通讯作者：
Nunes, EV
影响因子：
4.4
作者：
Blume, AW;Schmaling, KB;Marlatt, GA
通讯作者：
Marlatt, GA
影响因子：
4.2
作者：
GRANT, I;ADAMS, KM;RENNICK, PM
通讯作者：
RENNICK, PM
影响因子：
2.7
作者：
Czuchry, M;Dansereau, DF
通讯作者：
Dansereau, DF
影响因子：
2.7
作者：
FALSSTEWART, W;LUCENTE, S
通讯作者：
LUCENTE, S